CXCR4 and metastatic neoplasm: A study by Chen et al. showed that metastatic breast cancer is devoid of CD8+ cytotoxic T lymphocytes and that CD3+ T lymphocytes are mainly located at the margin of metastatic tumors, which is dependent on CXCR4 signaling in α-SMA+ MAFs [31].